Bromisoval

DB13370

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 223.07
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

665 Data
Buprenorphine Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Hydrocodone Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Magnesium sulfate The therapeutic efficacy of Bromisoval can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Bromisoval may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Mirtazapine Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Orphenadrine Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Pramipexole Bromisoval may increase the sedative activities of Pramipexole.
Ropinirole Bromisoval may increase the sedative activities of Ropinirole.
Rotigotine Bromisoval may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Bromisoval.
Suvorexant Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Thalidomide Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Bromisoval.
Sodium oxybate Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Ethanol Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Bromisoval may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Fluvoxamine The risk or severity of adverse effects can be increased when Bromisoval is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Bromisoval is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Bromisoval is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Bromisoval is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Bromisoval is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Bromisoval is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Bromisoval is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Bromisoval is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Bromisoval is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Bromisoval is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Bromisoval is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Bromisoval is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Bromisoval is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Bromisoval is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Bromisoval is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Bromisoval is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Bromisoval is combined with Alaproclate.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Bromisoval.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Bromisoval.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Bromisoval.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Bromisoval.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Bromisoval.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Bromisoval.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Bromisoval.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Bromisoval.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Bromisoval.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Bromisoval.
Dosulepin The risk or severity of CNS depression can be increased when Dosulepin is combined with Bromisoval.
Zopiclone The risk or severity of adverse effects can be increased when Bromisoval is combined with Zopiclone.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Bromisoval.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Bromisoval.
Tryptophan The risk or severity of CNS depression can be increased when Tryptophan is combined with Bromisoval.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bromisoval.
Lorazepam The risk or severity of CNS depression can be increased when Lorazepam is combined with Bromisoval.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Bromisoval.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Bromisoval.
Reserpine The risk or severity of CNS depression can be increased when Reserpine is combined with Bromisoval.
Eletriptan The risk or severity of CNS depression can be increased when Eletriptan is combined with Bromisoval.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Bromisoval.
Temazepam The risk or severity of CNS depression can be increased when Temazepam is combined with Bromisoval.
Reboxetine The risk or severity of CNS depression can be increased when Reboxetine is combined with Bromisoval.
Butabarbital The risk or severity of CNS depression can be increased when Butabarbital is combined with Bromisoval.
Butalbital The risk or severity of CNS depression can be increased when Butalbital is combined with Bromisoval.
Methysergide The risk or severity of CNS depression can be increased when Methysergide is combined with Bromisoval.
Cabergoline The risk or severity of CNS depression can be increased when Cabergoline is combined with Bromisoval.
Phenytoin The risk or severity of CNS depression can be increased when Phenytoin is combined with Bromisoval.
Topiramate The risk or severity of CNS depression can be increased when Topiramate is combined with Bromisoval.
Clemastine The risk or severity of CNS depression can be increased when Clemastine is combined with Bromisoval.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Bromisoval.
Etomidate The risk or severity of CNS depression can be increased when Etomidate is combined with Bromisoval.
Morphine The risk or severity of CNS depression can be increased when Morphine is combined with Bromisoval.
Talbutal The risk or severity of CNS depression can be increased when Talbutal is combined with Bromisoval.
Pentobarbital The risk or severity of CNS depression can be increased when Pentobarbital is combined with Bromisoval.
Valproic acid The risk or severity of CNS depression can be increased when Valproic acid is combined with Bromisoval.
Zolmitriptan The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Bromisoval.
Codeine The risk or severity of CNS depression can be increased when Codeine is combined with Bromisoval.
Dihydroergotamine The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Bromisoval.
Tolcapone The risk or severity of CNS depression can be increased when Tolcapone is combined with Bromisoval.
Hydromorphone The risk or severity of CNS depression can be increased when Hydromorphone is combined with Bromisoval.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Bromisoval.
Cetirizine The risk or severity of CNS depression can be increased when Cetirizine is combined with Bromisoval.
Protriptyline The risk or severity of CNS depression can be increased when Protriptyline is combined with Bromisoval.
Trimethadione The risk or severity of CNS depression can be increased when Trimethadione is combined with Bromisoval.
Clobazam The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Bromisoval.
Chlorzoxazone The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Bromisoval.
Clozapine The risk or severity of CNS depression can be increased when Clozapine is combined with Bromisoval.
Meprobamate The risk or severity of CNS depression can be increased when Meprobamate is combined with Bromisoval.
Thiethylperazine The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Bromisoval.
Palonosetron The risk or severity of CNS depression can be increased when Palonosetron is combined with Bromisoval.
Sulpiride The risk or severity of CNS depression can be increased when Sulpiride is combined with Bromisoval.
Alprazolam The risk or severity of CNS depression can be increased when Alprazolam is combined with Bromisoval.
Dexbrompheniramine The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Bromisoval.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 3
International Brands
  • Bromovalerylurea
  • Bromural
  • Brovarin

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul